Ipswich Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.03M Hold
46,912
1.27% 21
2026
Q1
$5.64M Sell
46,912
-50
-0.1% -$5.77K 1.33% 23
2025
Q4
$4.94M Buy
46,962
+275
+0.6% +$25.8K 1.14% 27
2025
Q3
$3.92M Sell
46,687
-725
-2% -$59.7K 0.92% 33
2025
Q2
$3.75M Sell
47,412
-1,508
-3% -$120K 0.91% 32
2025
Q1
$4.39M Sell
48,920
-2,858
-6% -$267K 1.09% 29
2024
Q4
$5.15M Sell
51,778
-14,333
-22% -$1.48M 1.24% 25
2024
Q3
$7.51M Sell
66,111
-360
-0.5% -$42.8K 1.74% 17
2024
Q2
$8.23M Hold
66,471
1.93% 13
2024
Q1
$8.77M Sell
66,471
-100
-0.2% -$12.3K 2.05% 9
2023
Q4
$7.26M Sell
66,571
-255
-0.4% -$26.5K 1.83% 14
2023
Q3
$6.88M Buy
66,826
+13,345
+25% +$1.44M 1.88% 10
2023
Q2
$6.17M Buy
53,481
+117
+0.2% +$13.3K 1.62% 18
2023
Q1
$5.68M Buy
53,364
+710
+1% +$76.7K 1.55% 17
2022
Q4
$5.84M Sell
52,654
-1,120
-2% -$114K 1.67% 13
2022
Q3
$4.63M Sell
53,774
-1,328
-2% -$119K 1.47% 19
2022
Q2
$5.02M Buy
55,102
+1,110
+2% +$98.4K 1.45% 18
2022
Q1
$4.43M Buy
53,992
+1,065
+2% +$84K 1.1% 27
2021
Q4
$4.06M Sell
52,927
-200
-0.4% -$15.9K 0.95% 34
2021
Q3
$3.99M Buy
53,127
+1,227
+2% +$93.3K 1.02% 29
2021
Q2
$4.04M Sell
51,900
-1,380
-3% -$103K 1.03% 31
2021
Q1
$3.92M Buy
53,280
+1,526
+3% +$113K 1.1% 28
2020
Q4
$4.04M Sell
51,754
-2,330
-4% -$178K 1.21% 25
2020
Q3
$4.28M Buy
54,084
+209
+0.4% +$16.4K 1.37% 18
2020
Q2
$3.98M Buy
53,875
+4,654
+9% +$350K 1.37% 18
2020
Q1
$3.61M Sell
49,221
-7,766
-14% -$610K 1.42% 18
2019
Q4
$4.95M Sell
56,987
-26
-0% -$2.14K 1.45% 16
2019
Q3
$4.58M Hold
57,013
1.46% 18
2019
Q2
$4.56M Sell
57,013
-708
-1% -$54.2K 1.46% 16
2019
Q1
$4.58M Buy
57,721
+1,209
+2% +$90.4K 1.5% 18
2018
Q4
$4.12M Buy
56,512
+110
+0.2% +$7.76K 1.51% 18
2018
Q3
$3.82M Buy
56,402
+1,781
+3% +$113K 1.29% 23
2018
Q2
$3.16M Buy
54,621
+3,985
+8% +$225K 1.45% 26
2018
Q1
$2.63M Buy
50,636
+188
+0.4% +$10.2K 1.11% 27
2017
Q4
$2.71M Hold
50,448
1.15% 28
2017
Q3
$3.08M Sell
50,448
-47
-0.1% -$2.85K 1.38% 25
2017
Q2
$3.09M Buy
50,495
+2,610
+5% +$159K 1.45% 25
2017
Q1
$2.9M Sell
47,885
-105
-0.2% -$6.37K 1.26% 27
2016
Q4
$2.7M Hold
47,990
1.22% 31
2016
Q3
$2.86M Hold
47,990
1.4% 25
2016
Q2
$2.64M Sell
47,990
-581
-1% -$30.9K 1.31% 29
2016
Q1
$2.51M Buy
48,571
+708
+1% +$34.7K 1.19% 33
2015
Q4
$2.41M Sell
47,863
-147
-0.3% -$7.41K 1.09% 40
2015
Q3
$2.26M Buy
48,010
+1,038
+2% +$55.1K 1.08% 38
2015
Q2
$2.55M Buy
46,972
+628
+1% +$35.2K 1.15% 35
2015
Q1
$2.54M Sell
46,344
-419
-0.9% -$23.7K 1.11% 35
2014
Q4
$2.53M Sell
46,763
-2,620
-5% -$146K 1.08% 37
2014
Q3
$2.79M Sell
49,383
-1,822
-4% -$102K 1.19% 35
2014
Q2
$2.83M Buy
51,205
+1,822
+4% +$99.4K 1.09% 37
2014
Q1
$2.67M Buy
49,383
+21
+0% +$1.09K 1.15% 36
2013
Q4
$2.36M Hold
49,362
0.98% 42
2013
Q3
$2.24M Sell
49,362
-864
-2% -$39.4K 1.01% 43
2013
Q2
$2.23M Buy
+50,226
New +$2.24M 0.96% 43

Other funds holding MRK

Ipswich Investment Management's MRK Position: Q2 2026 in Review

Ipswich Investment Management held its Merck (MRK) position steady in Q2 2026 at 46,912 shares worth $6.03M. The position accounts for 1.27% of the portfolio, ranked #21.

Ipswich Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.77M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ipswich Investment Management held 46,912 shares of Merck worth $6.03M as of Q2 2026.
  • Ipswich Investment Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 1.27% of Ipswich Investment Management's portfolio in Q2 2026, its #21 holding.
  • Ipswich Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Ipswich Investment Management's Merck position peaked at $8.77M in Q1 2024.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.